Pirfénidone
TED · 596736-2026Contract noticeCloses in 41 days · 2026-10-12
Buyer
Name—
Country—
Published2026-08-31
Deadline2026-10-12
Value
Estimated—
Awarded—
CPV codes
33670000 Medical equipment & pharmaceuticalsDescription
Le marché concerne les fournitures de la spécialité pharmaceutique contenant le principe actif « Pirfénidone ».
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-05-19 | Pomalidomide | — | 95% |
| 2026-08-19 | Infliximab | — | 95% |
| 2026-08-28 | Aflibercept | — | 93% |
| 2026-08-19 | Rituximab | — | 91% |
| 2026-07-07 | Bévacizumab | — | 91% |
| 2026-05-19 | Innovation de produits pour Tabloo | — BE | 88% |